Clearside Biomedical
A biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases. Learn more
Launch date
Employees
Market cap
$91.9m
Enterprise valuation
$63m (Public information from Sep 2024)
Share price
$1.28 CLSD
Alpharetta Georgia (HQ)
Authorizing premium user...